Seattle Genetics (SGEN -1.1%) CEO Clay Siegall says it's not the right time to sell the company...

|About: Seattle Genetics, Inc. (SGEN)|By:, SA News Editor

Seattle Genetics (SGEN -1.1%) CEO Clay Siegall says it's not the right time to sell the company with its pipeline and growth trajectory looking strong. Though it's more than a little speculative that a major buyer would still be interested in an acquisition after shares of SGEN ran up over 52% YTD on the potential for Adcetris, the CEO's bravado still provides guidance on the M&A front.